Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A C Delaney

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Epidemiology|May 7, 2009
The impact of unmeasured baseline effect modification on estimates from an inverse probability of treatment weighted logistic modelJoseph A C Delaney, Robert W Platt, Samy Suissa
Pharmacoepidemiology and Drug Safety|March 5, 2014
The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartanWendy Camelo Castillo, Joseph A C Delaney, Til Stürmer
Pharmacoepidemiology and Drug Safety|May 14, 2009
Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation studyRaluca Ionescu-Ittu, Joseph A C Delaney, Michal Abrahamowicz
Pharmacoepidemiology and Drug Safety|October 25, 2008
Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarctionJoseph A C Delaney, Stella S Daskalopoulou, Samy Suissa
Statistics in Medicine|February 7, 2008
Impact of mis-specification of the treatment model on estimates from a marginal structural modelGeneviève Lefebvre, Joseph A C Delaney, Robert W Platt
Pharmacoepidemiology and Drug Safety|October 1, 2015
Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication useAndrew J Spieker, Joseph A C Delaney, Robyn L McClelland
Pharmacoepidemiology and Drug Safety|February 12, 2008
Validating the effects of drug treatment on blood pressure in the General Practice Research DatabaseJoseph A C Delaney, Erica E M Moodie, Samy Suissa
British Journal of Clinical Pharmacology|January 31, 2012
Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated diseaseDaniel Suissa, Joseph A C Delaney, Sandra Dial, et al.
BMC Pregnancy and Childbirth|January 21, 2014
Anti-diabetic drug utilization of pregnant diabetic women in us managed careCaitlin A Knox, Joseph A C Delaney, Almut G Winterstein
Observational Studies|June 28, 2021
Semi-parametric Estimation of Biomarker Age Trends with Endogenous Medication Use in Longitudinal DataAndrew J Spieker, Joseph A C Delaney, Robyn L McClelland
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Epidemiology|May 7, 2009
The impact of unmeasured baseline effect modification on estimates from an inverse probability of treatment weighted logistic modelJoseph A C Delaney, Robert W Platt, Samy Suissa
Pharmacoepidemiology and Drug Safety|March 5, 2014
The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartanWendy Camelo Castillo, Joseph A C Delaney, Til Stürmer
Pharmacoepidemiology and Drug Safety|May 14, 2009
Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation studyRaluca Ionescu-Ittu, Joseph A C Delaney, Michal Abrahamowicz
Pharmacoepidemiology and Drug Safety|October 25, 2008
Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarctionJoseph A C Delaney, Stella S Daskalopoulou, Samy Suissa
Statistics in Medicine|February 7, 2008
Impact of mis-specification of the treatment model on estimates from a marginal structural modelGeneviève Lefebvre, Joseph A C Delaney, Robert W Platt
Pharmacoepidemiology and Drug Safety|October 1, 2015
Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication useAndrew J Spieker, Joseph A C Delaney, Robyn L McClelland
Pharmacoepidemiology and Drug Safety|February 12, 2008
Validating the effects of drug treatment on blood pressure in the General Practice Research DatabaseJoseph A C Delaney, Erica E M Moodie, Samy Suissa
British Journal of Clinical Pharmacology|January 31, 2012
Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated diseaseDaniel Suissa, Joseph A C Delaney, Sandra Dial, et al.
BMC Pregnancy and Childbirth|January 21, 2014
Anti-diabetic drug utilization of pregnant diabetic women in us managed careCaitlin A Knox, Joseph A C Delaney, Almut G Winterstein
Observational Studies|June 28, 2021
Semi-parametric Estimation of Biomarker Age Trends with Endogenous Medication Use in Longitudinal DataAndrew J Spieker, Joseph A C Delaney, Robyn L McClelland
Pageof 12